Efficacy and safety of canagliflozin in type 2 diabetes mellitus: systematic review of randomized controlled trials.
about
A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus.The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations.Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus.
P2860
Efficacy and safety of canagliflozin in type 2 diabetes mellitus: systematic review of randomized controlled trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Efficacy and safety of canagli ...... randomized controlled trials.
@en
type
label
Efficacy and safety of canagli ...... randomized controlled trials.
@en
prefLabel
Efficacy and safety of canagli ...... randomized controlled trials.
@en
P2093
P2860
P1476
Efficacy and safety of canagli ...... f randomized controlled trials
@en
P2093
Ghanshyam Mali
Neelam Kaushal
Rizwana Parveen
P2860
P304
P356
10.1517/14656566.2016.1109629
P407
P577
2015-12-09T00:00:00Z